Skip to main content

Welcome to the fourth installment of Arnold & Porter’s Virtual and Digital Health Digest. This edition primarily covers January 2023 highlights across the virtual and digital health space. This digest focuses on key virtual and digital health and telehealth-related developments in the United States, United Kingdom, and European Union in the healthcare, regulatory, intellectual property, and privacy spaces.

In this issue, you will find the following:

U.S. News

  • FDA Regulatory Updates
  • Healthcare Fraud and Abuse Updates
  • Provider Reimbursement Updates
  • Privacy Updates

EU and UK News

  • Regulatory Updates
  • Privacy Updates
  • Reimbursement Updates
  • Product Liability Updates
  • Intellectual Property Updates

Since going to press with this edition, the DEA announced pending publication of a proposed rule addressing permanent regulatory telemedicine flexibilities associated with prescribing Schedules III and IV drugs. The full text of the proposals may be found here and here. Stay tuned for more information in our next edition.  

Click here for additional issues of the Virtual and Digital Health Digest

Click here to opt into our mailing list for future issues of the Virtual and Digital Health Digest 

© Arnold & Porter Kaye Scholer LLP 2023 All Rights Reserved. This newsletter is intended to be a general summary of the law and does not constitute legal advice. You should consult with counsel to determine applicable legal requirements in a specific fact situation.